The Alliance for Regenerative Medicine (ARM) is an international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM represents the interests of 400+ members across 25 countries, including small and large companies, academic research institutions, major medical centers and patient groups.
Key information and resources provided on the site include:
A-Gene is a case study-based guide to integrating Quality by design (QbD) principles in gene therapy Chemistry Manufacturing & Control (CMC) programs. Learn more:
A-Cell is a case study-based guide to integrating Quality by design (QbD) principles in cell therapy Chemistry Manufacturing & Control (CMC) programs. Learn more:
ARM’s annual update on the sector’s progress and outlook
ARM's report on market access to ATMPs in key European countries. Learn more:
Additional information and resources developed by ARM: